Bot Image unveiled the fact that its ProstatID ™ software was also FDA-cleared for lesion detection, segmentation AND classification. Dr. Randall Jones, CEO and founder of Bot Image noted that ...

The U.S. FDA gave Bot Image Inc. a coveted threefer with 510(k) clearance for its Prostatid artificial intelligence (AI) software for detection, diagnosis and monitoring of prostate cancer using both ...

CEOCFO Interviews Bot Image, Inc. Founder/CEO Dr. Randall W. Jones, about their AI algorithm-based ProstatID™ for Prostate Cancer Detection Bot Image’s mission is to develop software tools ...